A Review of Classification of Emerging Excipients in Parenteral Medications
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2003
Volume 27
Issue 3
As parenteral drug delivery becomes more complex and sophisticated, excipients that can facilitate drug (or gene) delivery to specific therapeutic targets will be required. An overwhelming majority of these excipients are derived from natural sources.
Articles in this issue
The Clarification of Bioreactor Cell Cultures for Biopharmaceuticals
Standards for Supplements
Concept Paper Discusses Update of Aspetic Processing Guidelines
Outsourcing Outlook March 2003
A Review of Classification of Emerging Excipients in Parenteral Medications
March 2003
Effects of Breadfruit and Cocoyam Starch Mucilage Binders. On Disintegration and Dissolution Behaviors of Paracetamol Tablet Formulations.
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
